SMALL CAP SHARE IDEAS: Circassia Pharmaceuticals one for the recovery portfolio as sales pick up

Investors have had to be patient waiting for AIM-listed biotech Circassia Pharmaceuticals to come good, but things might now be turning in its favour. A recent trading update highlighted good sales growth while cash – another key metric for any early-stage biotech – was healthier than expected. Circassia was caught up last year in the … Read more

Terry Smith says he’s worth his £16m pay. I agree, says JEFF PRESTRIDGE

Fund manager Terry Smith is the Cristiano Ronaldo of the investment world.  He is right at the top of his profession and, like the footballing maestro, he is handsomely rewarded for his particular ‘craft’ – an ability to generate stellar returns for investors that most rival managers do not possess. Yet, while most people accept … Read more

Will the wellness craze make you a healthy profit?

It’s not uncommon for our health and fitness New Year resolutions to slowly fizzle out by mid-January.  But that doesn’t mean you can’t still reap the benefits of the booming wellness craze through your personal investment portfolio. The so-called wellness lifestyle is now so popular in the UK that the industry is worth £20.6 billion, … Read more

AVIVA UK LISTED EQUITY INCOME: Fund aims to deliver through thick and thin

AVIVA UK LISTED EQUITY INCOME: The fund that aims to deliver returns through thick and thin By Jeff Prestridge for The Mail on Sunday Published: 22:00 GMT, 23 November 2019 | Updated: 11:11 GMT, 25 November 2019 Fund manager Chris Murphy has worked in the City for more than 30 years – running money both … Read more